Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)NUVO

Upturn stock ratingUpturn stock rating
Holdco Nuvo Group D.G Ltd. Ordinary Shares
$0.01
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/13/2024: NUVO (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: 5.02%
Upturn Advisory Performance Upturn Advisory Performance4
Avg. Invested days: 142
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 2
Last Close 09/13/2024
Type: Stock
Today’s Advisory: PASS
Profit: 5.02%
Avg. Invested days: 142
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 2
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/13/2024
Upturn Advisory Performance Upturn Advisory Performance4

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 5.65M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -1.01
Volume (30-day avg) 236467
Beta -0.41
52 Weeks Range 0.01 - 12.15
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 5.65M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -1.01
Volume (30-day avg) 236467
Beta -0.41
52 Weeks Range 0.01 - 12.15
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -17524.49%

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Revenue by Products

Revenue by Geography

Valuation

Trailing PE -
Forward PE -
Enterprise Value 11392203
Price to Sales(TTM) 2.1
Enterprise Value to Revenue 64.73
Enterprise Value to EBITDA -
Shares Outstanding 33261500
Shares Floating 9927622
Percent Insiders 39.62
Percent Institutions 1.44
Trailing PE -
Forward PE -
Enterprise Value 11392203
Price to Sales(TTM) 2.1
Enterprise Value to Revenue 64.73
Enterprise Value to EBITDA -
Shares Outstanding 33261500
Shares Floating 9927622
Percent Insiders 39.62
Percent Institutions 1.44

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Holdco Nuvo Group D.G Ltd. Ordinary Shares: A Comprehensive Overview

Company Profile:

Holdco Nuvo Group D.G Ltd. (HNUD) is a holding company founded in 2021 and incorporated in the British Virgin Islands. It has no operating subsidiaries and relies on passive investments for revenue generation. As of November 2023, the company is actively seeking acquisition targets.

Leadership and Corporate Structure:

HNUD's leadership team comprises:

  • David Grimaldi: President, CEO, and Director
  • David DeStefano: Chief Financial and Compliance Officer
  • Timothy McCarthy: Director

The company operates a lean corporate structure with headquarters in Miami, Florida.

Top Products and Market Share:

HNUD currently has no operating products or services. It generates revenue through passive investments in securities through its wholly-owned subsidiary, DG Capital LLC. As of November 2023, its primary holding is an investment in 2MPower Holding LLC, a renewable energy holding company.

Total Addressable Market:

HNUD's total addressable market depends on the target companies it acquires. Given the company's focus on acquisitions, its potential market reach could encompass various industries and businesses.

Financial Performance:

Since HNUD is relatively new and has no ongoing operations, there are limited financial data available. However, it reported a net loss of $9.4 million in 2022.

Dividends and Shareholder Returns:

HNUD has not yet paid any dividends and does not currently expect to do so in the near future.

Growth Trajectory:

HNUD's growth trajectory is dependent on its acquisition strategy. The company aims to identify and acquire undervalued companies with significant growth potential.

Market Dynamics:

HNUD operates in the dynamic and competitive environment of mergers and acquisitions (M&A). The success of its strategy will depend on its ability to identify attractive targets, negotiate favorable terms, and successfully integrate acquisitions into its portfolio.

Competitors:

HNUD's competitors include other publicly traded holding companies seeking acquisitions, private equity firms, and strategic investors. Some notable competitors include:

  • M&A Acquisition Corp. (MACA)
  • Tuscan Holdings Corp. (THCB)
  • Ginkgo Bioworks Holdings, Inc. (DNA)

Potential Challenges and Opportunities:

HNUD faces potential challenges such as:

  • Integration difficulties: Successful integration of acquired companies can be challenging and require significant resources.
  • Market volatility: Fluctuations in the stock market can impact the value of HNUD's investments.
  • Competition: Intense competition in the M&A market can make it difficult to secure attractive acquisition targets.

Opportunities for HNUD:

  • Acquisition of undervalued companies: Identifying and acquiring companies with strong growth potential at attractive valuations could generate significant returns.
  • Diversification: Acquiring companies across different industries can diversify HNUD's revenue streams and mitigate risk.
  • Synergies: Leveraging synergies between acquired companies can improve operational efficiency and create value.

Recent Acquisitions:

As a newly formed company, HNUD has no recent acquisitions as of November 2023.

AI-Based Fundamental Rating:

An AI-based fundamental rating for HNUD is difficult to determine due to its limited operating history and financial data. As the company grows and its portfolio expands, a more accurate AI rating can be established.

Sources and Disclaimers:

Information for this overview was gathered from sources such as HNUD's SEC filings, press releases, and company website. This information is intended for informational purposes only and should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Holdco Nuvo Group D.G Ltd. Ordinary Shares

Exchange NYSE MKT Headquaters -
IPO Launch date 2024-05-01 CEO & Director Mr. Robert Maurice Powell Jr.
Sector Healthcare Website https://www.nuvocares.com
Industry Medical Devices Full time employees -
Headquaters -
CEO & Director Mr. Robert Maurice Powell Jr.
Website https://www.nuvocares.com
Website https://www.nuvocares.com
Full time employees -

Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​